Correlation Between BioNTech and Alvotech
Can any of the company-specific risk be diversified away by investing in both BioNTech and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Alvotech, you can compare the effects of market volatilities on BioNTech and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Alvotech.
Diversification Opportunities for BioNTech and Alvotech
Poor diversification
The 3 months correlation between BioNTech and Alvotech is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of BioNTech i.e., BioNTech and Alvotech go up and down completely randomly.
Pair Corralation between BioNTech and Alvotech
Given the investment horizon of 90 days BioNTech SE is expected to generate 1.27 times more return on investment than Alvotech. However, BioNTech is 1.27 times more volatile than Alvotech. It trades about -0.07 of its potential returns per unit of risk. Alvotech is currently generating about -0.18 per unit of risk. If you would invest 11,258 in BioNTech SE on December 30, 2024 and sell it today you would lose (1,763) from holding BioNTech SE or give up 15.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
BioNTech SE vs. Alvotech
Performance |
Timeline |
BioNTech SE |
Alvotech |
BioNTech and Alvotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioNTech and Alvotech
The main advantage of trading using opposite BioNTech and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Alvotech vs. Intracellular Th | Alvotech vs. Amphastar P | Alvotech vs. Assertio Therapeutics | Alvotech vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |